BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24423151)

  • 1. Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.
    Linssen AM; Sambeth A; Vuurman EF; Riedel WJ
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):961-77. PubMed ID: 24423151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and emotional behavioural changes associated with methylphenidate treatment: a review of preclinical studies.
    Britton GB
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):41-53. PubMed ID: 21439107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
    Kapur A
    CNS Drugs; 2020 Oct; 34(10):1045-1062. PubMed ID: 32794136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic α₁ - and α₂-receptors.
    Berridge CW; Shumsky JS; Andrzejewski ME; McGaughy JA; Spencer RC; Devilbiss DM; Waterhouse BD
    Biol Psychiatry; 2012 Mar; 71(5):467-73. PubMed ID: 21890109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
    Pearson DA; Santos CW; Casat CD; Lane DM; Jerger SW; Roache JD; Loveland KA; Lachar D; Faria LP; Payne CD; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):677-85. PubMed ID: 15167084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes.
    Müller U; Suckling J; Zelaya F; Honey G; Faessel H; Williams SC; Routledge C; Brown J; Robbins TW; Bullmore ET
    Psychopharmacology (Berl); 2005 Aug; 180(4):624-33. PubMed ID: 15830222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder.
    O'Toole K; Abramowitz A; Morris R; Dulcan M
    J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):531-8. PubMed ID: 9100428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge.
    Devilbiss DM; Berridge CW
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1327-35. PubMed ID: 16980569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?
    Maier LJ; Wunderli MD; Vonmoos M; Römmelt AT; Baumgartner MR; Seifritz E; Schaub MP; Quednow BB
    PLoS One; 2015; 10(6):e0129805. PubMed ID: 26107846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
    Pearson DA; Lane DM; Santos CW; Casat CD; Jerger SW; Loveland KA; Faria LP; Mansour R; Henderson JA; Payne CD; Roache JD; Lachar D; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):686-98. PubMed ID: 15167085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers.
    Linssen AM; Vuurman EF; Sambeth A; Riedel WJ
    Psychopharmacology (Berl); 2012 Jun; 221(4):611-9. PubMed ID: 22169884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive effects of methylphenidate and levodopa in healthy volunteers.
    Linssen AM; Sambeth A; Vuurman EF; Riedel WJ
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):200-6. PubMed ID: 24119823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls.
    Tomasi D; Volkow ND; Wang GJ; Wang R; Telang F; Caparelli EC; Wong C; Jayne M; Fowler JS
    Neuroimage; 2011 Feb; 54(4):3101-10. PubMed ID: 21029780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder.
    Bedard AC; Martinussen R; Ickowicz A; Tannock R
    J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):260-8. PubMed ID: 15076258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study.
    Schabram I; Henkel K; Mohammadkhani Shali S; Dietrich C; Schmaljohann J; Winz O; Prinz S; Rademacher L; Neumaier B; Felzen M; Kumakura Y; Cumming P; Mottaghy FM; Gründer G; Vernaleken I
    J Neurosci; 2014 Oct; 34(44):14769-76. PubMed ID: 25355228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants.
    Spencer RC; Berridge CW
    Neuropsychopharmacology; 2019 Sep; 44(10):1820-1827. PubMed ID: 30683912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.